🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 1 día
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/11/2023 84,50 85,01 82,86 84,42 -0,61% 2,54% 2.021.455
06/11/2023 85,35 85,60 84,69 84,94 -0,48% 1,07% 1.595.256
03/11/2023 86,90 87,47 84,53 85,35 -2,12% 3,38% 1.986.477
02/11/2023 87,20 88,68 86,69 87,20 +0,40% 2,28% 2.104.746
01/11/2023 86,30 87,51 86,02 86,85 +1,34% 1,73% 1.859.910
31/10/2023 84,79 85,98 84,50 85,70 +1,85% 1,75% 2.905.295
30/10/2023 81,50 84,42 81,18 84,14 +3,32% 3,98% 3.607.254
27/10/2023 85,00 88,21 80,60 81,44 -18,93% 8,95% 8.499.160
26/10/2023 100,58 101,12 100,16 100,46 -0,55% 0,95% 1.400.668
25/10/2023 99,28 101,16 99,03 101,02 +2,10% 2,15% 1.219.346
24/10/2023 97,68 99,10 97,55 98,94 +0,64% 1,59% 877.923
23/10/2023 98,83 99,04 97,87 98,31 -0,53% 1,18% 1.105.594
20/10/2023 98,51 99,31 97,86 98,83 +0,02% 1,47% 1.430.481
19/10/2023 99,75 99,99 98,09 98,81 -2,52% 1,90% 1.912.820
18/10/2023 101,92 103,10 101,30 101,36 -1,53% 1,77% 1.392.831
17/10/2023 103,48 104,12 102,62 102,94 -0,90% 1,45% 889.512
16/10/2023 104,00 104,00 103,14 103,88 +0,48% 0,83% 910.544
13/10/2023 104,00 104,32 103,18 103,38 -0,58% 1,10% 1.306.581
12/10/2023 103,62 104,10 103,14 103,98 +0,64% 0,93% 1.032.777
11/10/2023 104,00 104,00 102,88 103,32 +0,62% 1,08% 1.616.405
10/10/2023 102,64 102,96 101,08 102,68 +0,10% 1,83% 1.796.387
09/10/2023 102,26 103,50 102,06 102,58 +0,37% 1,41% 1.338.353
06/10/2023 103,28 103,28 101,38 102,20 -0,64% 1,84% 1.215.071
05/10/2023 102,20 102,86 101,38 102,86 +1,02% 1,45% 991.467
04/10/2023 101,92 102,82 101,40 101,82 +0,26% 1,39% 1.147.430
03/10/2023 102,52 103,12 101,26 101,56 -0,26% 1,81% 1.385.370
02/10/2023 101,52 103,06 100,08 101,82 +0,34% 2,94% 1.858.299
29/09/2023 100,30 102,08 99,68 101,48 +0,71% 2,39% 1.925.140
28/09/2023 101,00 101,86 100,30 100,76 -0,90% 1,54% 1.264.025
27/09/2023 102,98 102,98 101,46 101,68 -1,07% 1,48% 991.961